$2.43T
Total marketcap
$71.17B
Total volume
BTC 50.78%     ETH 15.61%
Dominance

Sinopharm Group Co. Ltd. SHTDY Stock

12.21 USD {{ price }} -2.709164% {{change_pct}}%
Exchange
Other OTC
Market Cap
7.74B USD
LOW - HIGH [24H]
12.19 - 12.24 USD
VOLUME [24H]
4K USD
{{ volume }}
P/E Ratio
6.10
Earnings per share
2 USD

Sinopharm Group Co. Ltd. Price Chart

Sinopharm Group Co. Ltd. SHTDY Financial and Trading Overview

Sinopharm Group Co. Ltd. stock price 12.21 USD
Previous Close 16.57 USD
Open 16.2 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 16.16 - 16.3 USD
52 Week Range 9.19 - 18.01 USD
Volume 32.7K USD
Avg. Volume 26.66K USD
Market Cap 10.52B USD
Beta (5Y Monthly) 0.819157
PE Ratio (TTM) 8.95055
EPS (TTM) 2 USD
Forward Dividend & Yield 0.6 (3.49%)
Ex-Dividend Date June 15, 2023
1y Target Est N/A

SHTDY Valuation Measures

Enterprise Value 57.76B USD
Trailing P/E 8.95055
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.019000763
Price/Book (mrq) 0.15012442
Enterprise Value/Revenue 0.104
Enterprise Value/EBITDA 2.291

Trading Information

Sinopharm Group Co. Ltd. Stock Price History

Beta (5Y Monthly) 0.819157
52-Week Change 40.18%
S&P500 52-Week Change 20.43%
52 Week High 18.01 USD
52 Week Low 9.19 USD
50-Day Moving Average 16.81 USD
200-Day Moving Average 13.17 USD

SHTDY Share Statistics

Avg. Volume (3 month) 26.66K USD
Avg. Daily Volume (10-Days) 52.77K USD
Shares Outstanding 624.13M
Float 36.64M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.016%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.82
Trailing Annual Dividend Yield 4.94%
5 Year Average Dividend Yield 342.00%
Payout Ratio 0.2728
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 1.55%
Operating Margin (ttm) 4.14%
Gross Margin 8.60%
EBITDA Margin 4.55%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 553.68B USD
Revenue Per Share (ttm) 887.24 USD
Quarterly Revenue Growth (yoy) -85.39%
Gross Profit (ttm) 47.43B USD
EBITDA 25.21B USD
Net Income Avi to Common (ttm) 8.64B USD
Diluted EPS (ttm) 1.82
Quarterly Earnings Growth (yoy) -74.59%

Balance Sheet

Total Cash (mrq) 55.22B USD
Total Cash Per Share (mrq) 647.96 USD
Total Debt (mrq) 69.59B USD
Total Debt/Equity (mrq) 63.22 USD
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 108.51

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Sinopharm Group Co. Ltd.

Country United States
State N/A
City Shanghai
Address Sinopharm Group Building
ZIP 200023
Phone 86 21 2305 2666
Website https://www.sinopharmgroup.com.cn
Industry Medical Distribution
Sector(s) Healthcare
Full Time Employees 114766

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Q&A For Sinopharm Group Co. Ltd. Stock

What is a current SHTDY stock price?

Sinopharm Group Co. Ltd. SHTDY stock price today per share is 12.21 USD.

How to purchase Sinopharm Group Co. Ltd. stock?

You can buy SHTDY shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Sinopharm Group Co. Ltd.?

The stock symbol or ticker of Sinopharm Group Co. Ltd. is SHTDY.

Which industry does the Sinopharm Group Co. Ltd. company belong to?

The Sinopharm Group Co. Ltd. industry is Medical Distribution.

How many shares does Sinopharm Group Co. Ltd. have in circulation?

The max supply of Sinopharm Group Co. Ltd. shares is 633.91M.

What is Sinopharm Group Co. Ltd. Price to Earnings Ratio (PE Ratio)?

Sinopharm Group Co. Ltd. PE Ratio is 6.10500000 now.

What was Sinopharm Group Co. Ltd. earnings per share over the trailing 12 months (TTM)?

Sinopharm Group Co. Ltd. EPS is 2 USD over the trailing 12 months.

Which sector does the Sinopharm Group Co. Ltd. company belong to?

The Sinopharm Group Co. Ltd. sector is Healthcare.